At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 196 enrolled
Drug / intervention
Ibuprofen Arginine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pain Reduction and Changes in Upper Limb Function Produced by Physiotherapy, Ibuprofen Arginine, Gabapentin and the Absence of Treatment, in Carpal Tunnel Syndrome
In Brief
A Phase 4 clinical trial evaluating Median nerve neural mobilization, Ibuprofen Arginine, and 1 other intervention for Carpal Tunnel Syndrome. Completed, enrolled 196 participants across 1 site.
Detailed Summary
In the present investigation the pain reduction effects of a physiotherapy technique will be compared to those produced by two different pharmaceutical treatments and also by the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarpal Tunnel Syndrome
CountriesVenezuela
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartAug 2019
Primary CompletionNov 2019
TodayJul 2026
First PostedJul 18, 2019
Enrollment StartAug 1, 2019
Primary CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.0 years ago
Interventions
Median nerve neural mobilizationother
Manual therapy maneuver performed in the upper limb.
Ibuprofen Argininedrug
Oral tablets
Gabapentindrug
oral capsules